Xiaoliang Qi, Ph.D, graduated from Engineering, Nanjing University of Technology and joined Wenzhou Medical University (Class D imported talents) in 2018. He mainly engages in the construction of hydrogel biomaterials and their applications in the fields of drug delivery, tissue engineering and matrix separation. At present, he is in charge of many scientific research projects, such as the key project, cultivation project of Wenzhou Medical University and the start-up Fund of Wenzhou Medical University. As the first/corresponding author, he has published more than 30 SCI papers on international high-level journals such as Chemical Engineering Journal, Journal of Hazardous Materials, ACS Applied Materials & Interfaces, Bioactive Materials, ACS Sustainable Chemistry & Engineering international, including 20 papers from the first area of the Chinese academy of sciences, total number of citations > 1300 (Google academic, 2020.10), and 6 Chinese invention patents and 2 authorized papers.